Clinical Trials
30 trialsHiTeCH
St Vincent's Hospital, Sydney
RAD402
Radiopharm Theranostics, Ltd
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
Virginia Commonwealth University
Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute
Long-Term Specified Drug Use-Results Survey for Xtandi Capsule
Astellas Pharma Inc
MEDCARE
Universitaire Ziekenhuizen KU Leuven
PROGNOSTICS
University Hospital, Basel, Switzerland
RAPIT
Bayer
Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer
RemeGen Co., Ltd.
RESPECT
European Institute of Oncology
MEDCARE
Universitaire Ziekenhuizen KU Leuven
PEACe
Jiangnan University
PROSPECT
AstraZeneca
Bone Marrow Suppression and Recovery During Radionuclide Treatment
Rigshospitalet, Denmark
PEARL
Technical University of Munich
Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute
ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer
Modra Pharmaceuticals
Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.
Osaka City University
CORE-OCU
Osaka City University
CoA-CRPC
Jiangnan University
Oral Calcitriol With Ketoconazole in CRPC
Inova Health Care Services
A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer
Sotio Biotech Inc.
Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients
Novartis
PERSEUS1
Institute of Cancer Research, United Kingdom
BARRIER-P
University Health Network, Toronto
A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer
Innocrin Pharmaceutical
STAMP
Tianjin Medical University Second Hospital
PRECHOL
University Hospital, Grenoble
The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer
Asan Medical Center